机译:244单药治疗与达拉夫氏症对日本男性泌尿和性功能的影响与良性前列腺增生相关的未经处理的下泌尿道症状
Department of Urology Showa University Koto Toyosu Hospital;
Department of Urology Showa University Fujigaoka Hospital;
Department of Urology Showa University Koto Toyosu Hospital;
Department of Urology Showa University Koto Toyosu Hospital;
Department of Urology Showa University Koto Toyosu Hospital;
Department of Urology Showa University Koto Toyosu Hospital;
Department of Urology Showa University Fujigaoka Hospital;
Department of Urology Showa University Fujigaoka Hospital;
Department of Urology Showa University Fujigaoka Hospital;
Department of Urology Showa University Fujigaoka Hospital;
Department of Urology Showa University Fujigaoka Hospital;
Department of Urology Showa University Fujigaoka Hospital;
Department of Urology Showa University Fujigaoka Hospital;
Department of Urology Showa University Fujigaoka Hospital;
Department of Urology Yokohama Shinmidori General Hospital;
机译:244单药治疗与达拉夫氏症对日本男性泌尿和性功能的影响与良性前列腺增生相关的未经处理的下泌尿道症状
机译:244单药治疗与达拉夫氏症对日本男性泌尿和性功能的影响与良性前列腺增生相关的未经处理的下泌尿道症状
机译:他达拉非对两种情况下性活跃男性继发于良性前列腺增生的下尿路症状和勃起功能障碍的影响:来自四项随机,安慰剂对照的他达拉非临床研究的汇总数据分析
机译:前列腺癌和良性前列腺增生样品的尿道前列腺特异性抗原糖族分析
机译:关于盆腔楼层和低尿路相关的特殊辅音学主题研究:对妇女两组队队之间的复发性尿路感染的关注,妇女不愿意使用局部阴道雌激素的评估
机译:Silodosin单一疗法的持续性和退出先前未接受治疗的日本下尿路症状提示良性前列腺增生的患者退出治疗的原因
机译:硅二蛋白酶单疗法的持续性以及戒断以前未经治疗的日本患者患者患有良性前列腺增生症状的患者